Twin Tree Management, LP Neurocrine Biosciences Inc Transaction History

Twin Tree Management, LP

$50 Billion
Q3 2024

A detailed history of Twin Tree Management, LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Twin Tree Management, LP holds 21,100 shares of NBIX stock, worth $2.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,100

Previous 14,100 49.65%

Holding current value

$2.89 Million

Previous $1.94 Million 25.14%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $3.22 Million - $4.3 Million	28,105 New	28,105 $3.24 Million
Q1 2024 May 09, 2024	SELL	$130.4 - $143.74 $2.32 Million - $2.55 Million	-17,764 Reduced 48.13%	19,147 $2.64 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $1.35 Million - $1.69 Million	12,712 Added 52.53%	36,911 $4.86 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $1.79 Million - $2.23 Million	19,022 Added 367.43%	24,199 $2.72 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $463,496 - $542,911	5,177 New	5,177 $488,000
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $718,938 - $842,211	7,812 Added 167.46%	12,477 $1.33 Million
Q2 2022 Aug 11, 2022	SELL	$75.79 - $100.07 $544,323 - $718,702	-7,182 Reduced 60.62%	4,665 $455,000
Q1 2022 May 11, 2022	BUY	$72.45 - $94.81 $655,889 - $858,314	9,053 Added 324.02%	11,847 $1.11 Million
Q4 2021 Feb 10, 2022	SELL	$79.65 - $106.22 $939,870 - $1.25 Million	-11,800 Reduced 80.86%	2,794 $238,000
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $765,536 - $879,683	-8,883 Reduced 37.84%	14,594 $1.4 Million
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $1.55 Million - $1.77 Million	17,310 Added 280.69%	23,477 $2.29 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $385,045 - $525,001	4,397 Added 248.42%	6,167 $600,000
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $511,030 - $636,980	-5,880 Reduced 76.86%	1,770 $170,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $238,380 - $335,036	2,479 Added 47.94%	7,650 $736,000
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $435,745 - $667,573	5,121 Added 10242.0%	5,171 $631,000
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $194,459 - $294,524	-2,589 Reduced 98.11%	50 $4,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $10,589 - $14,465	122 Added 4.85%	2,639 $284,000
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $33,444 - $40,498	399 Added 18.84%	2,517 $227,000
Q1 2019 May 10, 2019	SELL	$69.31 - $91.53 $84,488 - $111,575	-1,219 Reduced 36.53%	2,118 $187,000
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $227,983 - $414,989	3,337 New	3,337 $238,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account

Twin Tree Management, LP Neurocrine Biosciences Inc Transaction History